Jenny Tan - Concepedia

Author

Jenny Tan

Hospital for Sick Children ORCID

Also Known As

Ann Marie Swart, J Tan, J. TAN, J. Tan, JENNY C. Y. TAN, Jenny C. Y. Tan, Jenny C.Y. Tan, Jenny Tan

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Hospital for Sick Children University of Toronto Novartis (Switzerland)Novartis (United States)National Agency for New Technologies, Energy and Sustainable Economic Development

About

Jenny Tan is an author at Hospital for Sick Children specializing in medicine, natural sciences, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	2.3K
2	Natural Sciences	12	14	640
3	Engineering	2	2	26
4	Health Sciences	2	2	43
5	Public Health	1	1	16

Jenny Tan

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth F. Michael Yakes, Jason Chen, Jenny Tan, Molecular Cancer Therapeutics AngiogenesisNovel MetMedicineTumor GrowthVegfr Signaling	2011	1.3K
Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases Fawn Qian, Stefan Engst, Peiwen Yu, Cancer Research Tumor Cell GrowthNovel InhibitorVegf Receptor 2Tumor BiologyAngiogenesis	2009	336
Mutations in the MGAT2 gene controlling complex N-glycan synthesis cause carbohydrate-deficient glycoprotein syndrome type II, an autosomal recessive disease with defective brain development. Jenny Tan, John Dunn, Jaak Jaeken, PubMed	1996	156
Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis Yibin Wang, Jenny Tan, Mark Sutton‐Smith, Glycobiology GlycobiologyImmunologyPathologyDisease Gene IdentificationCellular Physiology	2001	135
Potent and Selective Non-Peptidic Inhibitors of Endothelin-Converting Enzyme-1 with Sustained Duration of Action Stéphane De Lombaert, Louis Blanchard, Lisa B. Stamford, Journal of Medicinal Chemistry Cgs 35066Selective Non-peptidic InhibitorsPharmacotherapyChemical BiologyPharmaceutical Chemistry	2000	100
Mild POMGnT1 Mutations Underlie a Novel Limb-Girdle Muscular Dystrophy Variant Emma Clement, Caroline Godfrey, Jenny Tan, Archives of Neurology	2008	89
The chalcone butein from Rhus verniciflua Stokes inhibits clonogenic growth of human breast cancer cells co-cultured with fibroblasts Michael Samoszuk, Jenny Tan, Guillaume Chorn BMC Complementary and Alternative Medicine	2005	81
The human UDP-N-Acetylglucosamine:alpha-6-d-Mannoside-beta-1,2-N-Acetylglucosaminyltransferase II Gene (MGAT2). Cloning of Genomic DNA, Localization to Chromosome 14q21, Expression in Insect Cells and Purification of the Recombinant Protein Jenny Tan, Giacomo D’Agostaro, Brad Bendiak, European Journal of Biochemistry GeneticsGlycobiologyGenomic MechanismMolecular BiologyMolecular Genetics	1995	80
Clonogenic growth of human breast cancer cells co-cultured in direct contact with serum-activated fibroblasts Michael Samoszuk, Jenny Tan, Guillaume Chorn Breast Cancer Research	2005	79
N-Phosphonomethyl Dipeptides and Their Phosphonate Prodrugs, a New Generation of Neutral Endopeptidase (NEP, EC 3.4.24.11) Inhibitors Stéphane De Lombaert, Mark D. Erion, Jenny Tan, Journal of Medicinal Chemistry	1994	79

Page 1